Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-027558
Filing Date
2021-05-13
Accepted
2021-05-13 16:16:06
Documents
71
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q ktra-10q_20210331.htm   iXBRL 10-Q 3321181
2 EX-31.1 ktra-ex311_6.htm EX-31.1 21534
3 EX-31.2 ktra-ex312_7.htm EX-31.2 21273
4 EX-32.1 ktra-ex321_9.htm EX-32.1 8814
5 EX-32.2 ktra-ex322_8.htm EX-32.2 8886
6 GRAPHIC gwl3ibqfw2zi000003.jpg GRAPHIC 58918
7 GRAPHIC gwl3ibqfw2zi000001.jpg GRAPHIC 67724
8 GRAPHIC gwl3ibqfw2zi000002.jpg GRAPHIC 40295
  Complete submission text file 0001564590-21-027558.txt   10856684

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION SCHEMA ktra-20210331.xsd EX-101.SCH 80476
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ktra-20210331_cal.xml EX-101.CAL 33251
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ktra-20210331_def.xml EX-101.DEF 293118
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE ktra-20210331_lab.xml EX-101.LAB 522316
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ktra-20210331_pre.xml EX-101.PRE 427137
14 EXTRACTED XBRL INSTANCE DOCUMENT ktra-10q_20210331_htm.xml XML 1865625
Mailing Address 12707 HIGH BLUFF DR., SUITE 200 SAN DIEGO CA 92130
Business Address 12707 HIGH BLUFF DR., SUITE 200 SAN DIEGO CA 92130 (858) 350-4364
Kintara Therapeutics, Inc. (Filer) CIK: 0001498382 (see all company filings)

EIN.: 990360497 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-37823 | Film No.: 21919845
SIC: 2834 Pharmaceutical Preparations